Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MB097 |
Trade Name | |
Synonyms | |
Drug Descriptions |
MB097 is a microbiome therapy consisting of nine strains of bacteria, which may increase anti-tumor immune response and inhibit tumor growth (Cancer Immunol Res (2022) 10 (1_Supplement): P074). |
DrugClasses | Microbiome 8 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MB097 | MB097 | 0 | 0 |
MB097 + Pembrolizumab | MB097 Pembrolizumab | 0 | 1 |